Charlotte leaned in next to her little brother only for excitable Louis to suddenly turn, accidentally leading to a clash of heads. A clip of the moment went newly viral on TikTok, where it was ...
Cheng Xin / Getty Images DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants. The maker of glucose monitoring devices said ...
Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous glucose monitor maker’s facilities last year. In a filing with the ...
SAN DIEGO, March 10, 2025--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Renée Galá to its Board of Directors ...
DexCom recently received a warning letter from the FDA, which pointed out issues in manufacturing processes and quality management. While these regulatory developments did not impact its ability ...
SAN DIEGO, February 27, 2025--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 46th Annual Raymond James Institutional Investors Conference on ...
Dexcom received a warning letter on March 4 after the Food and Drug Administration found problems at facilities in Arizona and California, the company revealed Friday in a securities filing. Dexcom ...
After a huge 4-1 win over Houston a week ago, Inter Miami was looking to maintain its momentum as it prepared to take on another 1-0-1 team in Charlotte FC. While a quick look at the Major League ...
Andy Drury has left his position as Folkestone Invicta manager. The news of Drury’s departure from the mid-table Isthmian Premier club came after Saturday’s 2-1 victory at second-bottom Bognor ...
Wells Fargo analyst Larry Biegelsen keeps an Overweight rating on DexCom (DXCM) with a $98 price target after the company disclosed that a warning letter was issued by the FDA following prior 483s.
Bengaluru: Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following inspections of its two key manufacturing facilities, sending its ...
DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San Diego, Calif., and Mesa, Ariz. related to concerns about manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results